PENICILLIN-2 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Penicillin-2, and when can generic versions of Penicillin-2 launch?
Penicillin-2 is a drug marketed by Teva and is included in one NDA.
The generic ingredient in PENICILLIN-2 is penicillin g potassium. There are ninety-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the penicillin g potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillin-2
A generic version of PENICILLIN-2 was approved as penicillin g potassium by SANDOZ on August 30th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PENICILLIN-2?
- What are the global sales for PENICILLIN-2?
- What is Average Wholesale Price for PENICILLIN-2?
Summary for PENICILLIN-2
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Clinical Trials: | 218 |
| Patent Applications: | 5,794 |
| DailyMed Link: | PENICILLIN-2 at DailyMed |
Recent Clinical Trials for PENICILLIN-2
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre Hospitalier Universitaire Dijon | PHASE3 |
| Qilu Pharmaceutical Co., Ltd. | PHASE1 |
| Rehman Medical Institute - RMI | PHASE4 |
US Patents and Regulatory Information for PENICILLIN-2
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | PENICILLIN-2 | penicillin g potassium | FOR SOLUTION;ORAL | 060307-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
